BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30270813)

  • 1. Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.
    Ma J; Huo X; Jarpe MB; Kavelaars A; Heijnen CJ
    Acta Neuropathol Commun; 2018 Oct; 6(1):103. PubMed ID: 30270813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effects of ACY-1215 Against Chemotherapy-Related Cognitive Impairment and Brain Damage in Mice.
    Wang D; Wang B; Liu Y; Dong X; Su Y; Li S
    Neurochem Res; 2019 Nov; 44(11):2460-2469. PubMed ID: 31571096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity.
    McAlpin BR; Mahalingam R; Singh AK; Dharmaraj S; Chrisikos TT; Boukelmoune N; Kavelaars A; Heijnen CJ
    Theranostics; 2022; 12(2):603-619. PubMed ID: 34976203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy.
    Krukowski K; Ma J; Golonzhka O; Laumet GO; Gutti T; van Duzer JH; Mazitschek R; Jarpe MB; Heijnen CJ; Kavelaars A
    Pain; 2017 Jun; 158(6):1126-1137. PubMed ID: 28267067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pifithrin-μ Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function.
    Chiu GS; Maj MA; Rizvi S; Dantzer R; Vichaya EG; Laumet G; Kavelaars A; Heijnen CJ
    Cancer Res; 2017 Feb; 77(3):742-752. PubMed ID: 27879267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits.
    Alexander JF; Seua AV; Arroyo LD; Ray PR; Wangzhou A; Heiβ-Lückemann L; Schedlowski M; Price TJ; Kavelaars A; Heijnen CJ
    Theranostics; 2021; 11(7):3109-3130. PubMed ID: 33537077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice.
    Zhang L; Liu C; Wu J; Tao JJ; Sui XL; Yao ZG; Xu YF; Huang L; Zhu H; Sheng SL; Qin C
    J Alzheimers Dis; 2014; 41(4):1193-205. PubMed ID: 24844691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC6 Inhibition Reverses Cisplatin-Induced Mechanical Hypersensitivity via Tonic Delta Opioid Receptor Signaling.
    Zhang J; Junigan JM; Trinh R; Kavelaars A; Heijnen CJ; Grace PM
    J Neurosci; 2022 Oct; 42(42):7862-7874. PubMed ID: 36096670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental neurotoxicity in the context of multiple sevoflurane exposures: Potential role of histone deacetylase 6.
    Li G; Du J; Wang L; Shi X
    Neurotoxicol Teratol; 2019; 74():106813. PubMed ID: 31251981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth.
    Van Helleputte L; Kater M; Cook DP; Eykens C; Rossaert E; Haeck W; Jaspers T; Geens N; Vanden Berghe P; Gysemans C; Mathieu C; Robberecht W; Van Damme P; Cavaletti G; Jarpe M; Van Den Bosch L
    Neurobiol Dis; 2018 Mar; 111():59-69. PubMed ID: 29197621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
    Noack M; Leyk J; Richter-Landsberg C
    Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury.
    Tang J; Shi Y; Liu N; Xu L; Zang X; Li P; Zhang J; Zheng X; Qiu A; Zhuang S
    Clin Sci (Lond); 2018 Feb; 132(3):339-359. PubMed ID: 29358506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline.
    Trzeciakiewicz H; Ajit D; Tseng JH; Chen Y; Ajit A; Tabassum Z; Lobrovich R; Peterson C; Riddick NV; Itano MS; Tripathy A; Moy SS; Lee VMY; Trojanowski JQ; Irwin DJ; Cohen TJ
    Nat Commun; 2020 Nov; 11(1):5522. PubMed ID: 33139698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
    Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
    J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice.
    Onishi T; Maeda R; Terada M; Sato S; Fujii T; Ito M; Hashikami K; Kawamoto T; Tanaka M
    Sci Rep; 2021 Jul; 11(1):15423. PubMed ID: 34326423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers.
    Ma J; Trinh RT; Mahant ID; Peng B; Matthias P; Heijnen CJ; Kavelaars A
    Pain; 2019 Dec; 160(12):2877-2890. PubMed ID: 31356453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment.
    Chiang ACA; Huo X; Kavelaars A; Heijnen CJ
    Brain Behav Immun; 2019 Jul; 79():319-325. PubMed ID: 30953771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau--an inhibitor of deacetylase HDAC6 function.
    Perez M; Santa-Maria I; Gomez de Barreda E; Zhu X; Cuadros R; Cabrero JR; Sanchez-Madrid F; Dawson HN; Vitek MP; Perry G; Smith MA; Avila J
    J Neurochem; 2009 Jun; 109(6):1756-66. PubMed ID: 19457097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
    Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
    Elife; 2021 Apr; 10():. PubMed ID: 33856345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.